Related Experiment Video
Updated: Dec 31, 2025

Author Spotlight: Establishing CENP-E Knockout HeLa Cells – A Novel Approach to Study Kinesin-7 CENP-E Biology and its Inhibitors
Published on: June 23, 2023
Photoswitchable CENP-E Inhibitor Enabling the Dynamic Control of Chromosome Movement and Mitotic Progression
Noushaba Nusrat Mafy1, Kazuya Matsuo1, Shota Hiruma2
1Research Institute for Electronic Science , Hokkaido University , Kita 20, Nishi 10 , Kita-ku, Sapporo , 001-0020 , Japan.
Abstract:
Interfering with mitosis is a potential cancer therapy strategy. However, the lack of controllability of antimitotic drugs in cell growth suppression causes severe side effects and limits their clinical utility. Herein, we developed an azobenzene-based photoswitchable inhibitor of CENP-E, a mitotic kinesin required for chromosome transportation. The new inhibitor enabled reversible photoswitching of CENP-E activity with ∼10-fold change in IC50 between cis and trans photoisomerization states both in vitro and in living cells. It also enabled repeatable photoswitching of CENP-E-dependent chromosome congression and hence mitotic progression with UV/vis light illumination cycles. Using this technique, we could specify the exact process of mitotic progression in which CENP-E plays an indispensable role. Our data demonstrate the power of a photochemical approach for highly controllable mitotic interference as well as for discovery of precise molecular functions in dynamic cellular processes.
Insights
This study introduces a light-controlled inhibitor for CENP-E, a key protein in cell division. This photoswitchable drug offers precise control over mitosis, potentially leading to safer and more effective cancer therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Interfering with mitosis is a promising cancer therapy strategy.
- Current antimitotic drugs lack precise control, leading to significant side effects.
- CENP-E, a mitotic kinesin, is crucial for chromosome transport during cell division.
Purpose of the Study:
- To develop a photoswitchable inhibitor for CENP-E.
- To achieve precise, light-controlled interference with mitosis.
- To explore the precise functions of CENP-E in cellular processes.
Main Methods:
- Development of an azobenzene-based photoswitchable CENP-E inhibitor.
- In vitro and in vivo assessment of inhibitor activity and photoswitching.
- UV/vis light illumination cycles to control inhibitor activity and observe effects on chromosome congression and mitotic progression.
Main Results:
- The inhibitor demonstrated reversible photoswitching of CENP-E activity with a ~10-fold change in IC50 between cis and trans states.
- Repeatable photoswitching of chromosome congression and mitotic progression was achieved using light.
- The study precisely identified the role of CENP-E in specific stages of mitotic progression.
Conclusions:
- A photochemical approach enables highly controllable interference with mitosis.
- This method allows for the discovery of precise molecular functions in dynamic cellular processes.
- The developed photoswitchable inhibitor holds potential for targeted cancer therapy with reduced side effects.
More Related Videos
09:41Functional Assessment of Kinesin-7 CENP-E in Spermatocytes Using In Vivo Inhibition, Immunofluorescence and Flow Cytometry
Published on: December 28, 2021
08:13Spatiotemporal Subcellular Manipulation of the Microtubule Cytoskeleton in the Living Preimplantation Mouse Embryo using Photostatins
Published on: November 30, 2021
Related Concept Videos
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
Anaphase Promoting Complex
Inhibition of Cdk Activity
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Positive Regulator Molecules